文献速递神经MR

高级别胶质瘤患者术后放疗后磁共振成像在临床决策中的作用

Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.
PubMed 文献 · Radiol Med · 2022-05-24

本研究回顾性分析149例高级别胶质瘤患者放疗-化疗后首次至第三次MRI评估、疾病进展相关症状及治疗策略改变。无症状患者首次、第二次、第三次MRI诊断复发比例分别为2/122(1.6%)、5/106(4.7%)、8/92(8.6%);有症状患者相应治疗后改变方案比例分别为16/27(59.2%)、16/24(66.6%)、13/16(82.2%)。发生远处进展影像征象的患者中10/14有症状并改变治疗。

要点

  • 有症状患者首次MRI后改变治疗策略比例达59.2%(16/27),高于无症状患者的1.6%(2/122)。
  • 放疗-化疗结束后6个月内MRI主要导致有症状患者治疗策略改变。
  • 发生远处进展影像征象的患者中,10/14有症状并改变治疗。

核心结论

  • 放疗-化疗结束后6个月内进行的MRI主要在有症状患者中导致治疗策略改变。

研究设计与样本

  • 回顾性研究,纳入2013年5月至2020年7月期间治疗的149例高级别胶质瘤患者,记录放疗-化疗后影像学评估、疾病进展相关症状及治疗策略改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The present study aims to investigate the role of the first magnetic resonances (MRI) following radio-chemotherapy (RT-CT) in patients diagnosed with high-grade glioma.

METHODS: We retrospectively recorded radiological evaluations following RT-CT, symptoms related to disease progression (avoiding any sign due to radiotherapy or chemotherapy) and the change of therapeutic strategy.

RESULTS: In March 2021, at data analysis, the data of 149 patients diagnosed with high-grade glioma and treated between May 2013 and July 2020 were retrieved for the present analysis. Two out of 122 (1.6%), 5 out of 106 (4.7%) and 8 out of 92 (8.6%) asymptomatic patients received the diagnosis of disease recurrence at the time of the first, second and third MRI, respectively. Otherwise, 16 out of 27 (59.2%), 16 out of 24 (66.6%) and 13 out of 16 (82.2%) symptomatic patients changed their therapy after the first, second and third MRI, respectively. Among patients that experienced radiological signs of distant progression, 10 out of 14 were symptomatic and changed their therapy.

CONCLUSIONS: MRIs performed by 6 months after the end of RT-CT lead to change treatment strategy mostly in symptomatic patients.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Pasqualetti, Malfatti, Cantarella, et al. Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma. Radiol Med. 2022. PMID: 35608757. doi:10.1007/s11547-022-01502-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。